Four insights:
1. The company is developing therapies to improve functional recovery of patients with spinal cord injuries.
2. GTX Medical BV is designing an implantable spinal cord stimulation device with real-time motion feedback known as targeted epidural spine stimulation.
3. The company is also developing a transcutaneous spinal cord stimulation device to restore upper limb movement and hand function.
4. The Christopher & Dana Reeve Foundation, a nonprofit focused on advancing spinal cord injury research, will be a shareholder in the company.
More articles on devices:
7 big moves for Hospital for Special Surgery in 2019
5 highest paying physician specialties — Neurosurgeon No. 1 at $401k
Dr. Thomas Loftus: How a single-payer system would harm spine practice in the US
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
